| Date | Form | Description | Docs | XBRL | Pages |
| 12/04/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/04/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/15/12 | CT ORDER | Confidential treatment order |
|
1 | |
| 11/08/12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
2 | |
| 11/08/12 | 8-K | Current report filing |
|
20 | |
| 11/06/12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
2 | |
| 10/29/12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 10/12/12 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
52 | |
| 10/10/12 | 8-K | Current report filing |
|
20 | |
| 10/10/12 | 8-K | Current report filing |
|
3 |
Latest News & Events
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
Read More...Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Read More...Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...